47 Shrinking Coarsened Win Ratio and Testing of Composite Endpoint

OBJECTIVES/GOALS: Win ratio (WR) is an increasingly popular composite endpoint in clinical trials. A typical set up in cardiovascular trials is to use death as the first and hospitalization as the second layer. However, the power of WR may be reduced by its strict hierarchical structure. Our study a...

Full description

Bibliographic Details
Main Authors: Yunhan Mou, Scott Hummel, Tassos Kyriakides, Yuan Huang
Format: Article
Language:English
Published: Cambridge University Press 2023-04-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866123001383/type/journal_article
_version_ 1797840513971257344
author Yunhan Mou
Scott Hummel
Tassos Kyriakides
Yuan Huang
author_facet Yunhan Mou
Scott Hummel
Tassos Kyriakides
Yuan Huang
author_sort Yunhan Mou
collection DOAJ
description OBJECTIVES/GOALS: Win ratio (WR) is an increasingly popular composite endpoint in clinical trials. A typical set up in cardiovascular trials is to use death as the first and hospitalization as the second layer. However, the power of WR may be reduced by its strict hierarchical structure. Our study aims to release the oracular hierarchical structure of the standard WR. METHODS/STUDY POPULATION: Addressing the power reduction of WR when treatment effects lie in the subsequent layers, we propose an improved method, Shrinking Coarsened Win Ratio (SCWR), that releases the oracular hierarchical structure of the standard WR approach by adding layers with coarsened thresholds shrinking to zero. A weighted adaptive approach is developed to determine the thresholds in SCWR. We conducted simulations to compare the performance of our improved method and the standard Win Ratio (WR) under different scenarios of follow-up time, association between events, and treatment effect levels. We also illustrate our method by re-analyzing real-world cardiovascular trials. RESULTS/ANTICIPATED RESULTS: First, the developed Shrinking Coarsened Win Ratio (SCWR) method preserves the good statistical properties of the standard WR and has a greater capacity to detect treatment effects on subsequent layer outcomes. Second, the SCWR method outperforms the standard approach under the scenarios in our simulations in terms of gaining higher power. In practice, we expect that SCWR can better detect the treatment effects. Finally, we will offer convenient software tools and clear tutorials for implementing the SCWR method in future studies, which include both unstratified and stratified designs. DISCUSSION/SIGNIFICANCE: The developed SCWR provides a more flexible way of combining the top layer and subsequent layers (e.g., the fatal and non-fatal endpoints) under the hierarchical structure and achieves a higher power in simulation. This nonparametric approach can accommodate different types of outcomes, including time-to-event, continuous, and categorical ones.
first_indexed 2024-04-09T16:16:35Z
format Article
id doaj.art-f679f725beca4a46a8bf68db4252bfc3
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-09T16:16:35Z
publishDate 2023-04-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-f679f725beca4a46a8bf68db4252bfc32023-04-24T05:55:55ZengCambridge University PressJournal of Clinical and Translational Science2059-86612023-04-017121310.1017/cts.2023.13847 Shrinking Coarsened Win Ratio and Testing of Composite EndpointYunhan Mou0Scott Hummel1Tassos Kyriakides2Yuan Huang3Yale University, School of Public HealthVA Ann Arbor Health System, University of Michigan School of MedicineVA Connecticut Health System, CSP Coordinating Center (CSPCC) West Haven Yale University, School of Public HealthYale University, School of Public Health VA Connecticut Health System, CSP Coordinating Center (CSPCC) West HavenOBJECTIVES/GOALS: Win ratio (WR) is an increasingly popular composite endpoint in clinical trials. A typical set up in cardiovascular trials is to use death as the first and hospitalization as the second layer. However, the power of WR may be reduced by its strict hierarchical structure. Our study aims to release the oracular hierarchical structure of the standard WR. METHODS/STUDY POPULATION: Addressing the power reduction of WR when treatment effects lie in the subsequent layers, we propose an improved method, Shrinking Coarsened Win Ratio (SCWR), that releases the oracular hierarchical structure of the standard WR approach by adding layers with coarsened thresholds shrinking to zero. A weighted adaptive approach is developed to determine the thresholds in SCWR. We conducted simulations to compare the performance of our improved method and the standard Win Ratio (WR) under different scenarios of follow-up time, association between events, and treatment effect levels. We also illustrate our method by re-analyzing real-world cardiovascular trials. RESULTS/ANTICIPATED RESULTS: First, the developed Shrinking Coarsened Win Ratio (SCWR) method preserves the good statistical properties of the standard WR and has a greater capacity to detect treatment effects on subsequent layer outcomes. Second, the SCWR method outperforms the standard approach under the scenarios in our simulations in terms of gaining higher power. In practice, we expect that SCWR can better detect the treatment effects. Finally, we will offer convenient software tools and clear tutorials for implementing the SCWR method in future studies, which include both unstratified and stratified designs. DISCUSSION/SIGNIFICANCE: The developed SCWR provides a more flexible way of combining the top layer and subsequent layers (e.g., the fatal and non-fatal endpoints) under the hierarchical structure and achieves a higher power in simulation. This nonparametric approach can accommodate different types of outcomes, including time-to-event, continuous, and categorical ones.https://www.cambridge.org/core/product/identifier/S2059866123001383/type/journal_article
spellingShingle Yunhan Mou
Scott Hummel
Tassos Kyriakides
Yuan Huang
47 Shrinking Coarsened Win Ratio and Testing of Composite Endpoint
Journal of Clinical and Translational Science
title 47 Shrinking Coarsened Win Ratio and Testing of Composite Endpoint
title_full 47 Shrinking Coarsened Win Ratio and Testing of Composite Endpoint
title_fullStr 47 Shrinking Coarsened Win Ratio and Testing of Composite Endpoint
title_full_unstemmed 47 Shrinking Coarsened Win Ratio and Testing of Composite Endpoint
title_short 47 Shrinking Coarsened Win Ratio and Testing of Composite Endpoint
title_sort 47 shrinking coarsened win ratio and testing of composite endpoint
url https://www.cambridge.org/core/product/identifier/S2059866123001383/type/journal_article
work_keys_str_mv AT yunhanmou 47shrinkingcoarsenedwinratioandtestingofcompositeendpoint
AT scotthummel 47shrinkingcoarsenedwinratioandtestingofcompositeendpoint
AT tassoskyriakides 47shrinkingcoarsenedwinratioandtestingofcompositeendpoint
AT yuanhuang 47shrinkingcoarsenedwinratioandtestingofcompositeendpoint